The patent ductus arteriosus (PDA) is the most commonly found cardiac condition in
neonates. While there have been several studies and thousands of publications on the topic …

Background Cyclooxygenase inhibitors are commonly used in infants with patent ductus
arteriosus (PDA), but the benefit of these drugs is uncertain. Methods In this multicenter …

Background The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus
arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with …

Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid
exposure as part of multimodal analgesia, and is the only compound recommended to treat …

Objective To demonstrate the association between the duration of significant patent ductus
arteriosus (PDA) and bronchopulmonary dysplasia (BPD) in extremely preterm infants …

Persistent Patent ductus arteriosus (PDA) is a common finding in extremely low gestational
age newborn infants and its prevalence is inversely proportional to the gestational age. The …

In preterm infants, failure or delay in spontaneous closure of Ductus Arteriosus (DA),
resulting in the condition of Patent Ductus Arteriosus (PDA), represents a significant issue. A …

Background: Patent ductus arteriosus (PDA) is a dramatically harmful disease in the
neonatal period, in particular common in preterm infants, and our study was to determine …

Background: Patent ductus arteriosus (PDA) is a common problem in the preterm infants.
The frequency of PDA varies with the time of study, and the characteristics of the population …

What is new for patent ductus arteriosus management in prema... : Current Opinion in
Pediatrics What is new for patent ductus arteriosus management in premature infants in …